Finance

Lists
Why is GANX up २.७८%?
Dive Deeper
GANX:NASDAQ
Gain Therapeutics Inc
US$ १.११
+२.७८%
(+०.०३०) 1D
US$ १.१६
+४.३८% (+०.०४९)
After hours
Closed: नोभेम्बर ११, १६:००:०१ GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GANX...
Open
US$ १.१२
High
US$ १.१६
Low
US$ १.०७
Mkt. cap
४.८४ करोड
Avg. vol.
५.५३ लाख
Volume
२.९३ लाख
52-wk high
US$ ४.३४
52-wk low
US$ ०.९४
EPS
-US$ ०.५१
Beta
०.२९
Shares outstanding
४.३६ करोड
No. of employees
२१
Open
US$ १.१२
High
US$ १.१६
Low
US$ १.०७
Mkt. cap
४.८४ करोड
Avg. vol.
५.५३ लाख
Volume
२.९३ लाख
52-wk high
US$ ४.३४
52-wk low
US$ ०.९४
EPS
-US$ ०.५१
Beta
०.२९
Shares outstanding
४.३६ करोड
No. of employees
२१
News stories
From web sources and news partners
About Gain Therapeutics Inc
CEO-
Employees२१
Founded२०१७
Headquarters-
SectorHealth Care
Industry-
Websitegaintherapeutics.com
Analyst ratings
Based on 5 analysts giving stock ratings to GANX in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for GANX in the last 3 months.
Highest
Current US$ १.११
US$ ८.०० (+६२०.७२%)
Average
US$ ७.२० (+५४८.६५%)
Lowest
US$ ५.०० (+३५०.४५%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Shrader
BTIG
Buy
Maintained
US$ ५.००
+३५०.५%
11/10/2026
Jason McCarthy
Maxim Group
Buy
Maintained
US$ ७.००
+५३०.६%
11/10/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
US$ ८.००
+६२०.७%
10/05/2026
Boobalan Pachaiyappan
Roth MKM
Buy
Maintained
US$ ८.००
+६२०.७%
08/18/2026
Unknown Analyst
Oppenheimer
Buy
Maintained
US$ ८.००
+६२०.७%
08/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
२८.१२ लाख
२३.१६ लाख
२७.४१ लाख
२१.१७ लाख
Cost of revenue
२८.१२ लाख
२३.१६ लाख
२७.४१ लाख
२१.१७ लाख
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१९.७९ लाख
२१.५५ लाख
२६.१२ लाख
२५.६५ लाख
Operating expense
१९.७९ लाख
२१.५५ लाख
२६.१२ लाख
२५.६५ लाख
Total operating expenses
४७.९१ लाख
४४.७१ लाख
५३.५४ लाख
४६.८१ लाख
Operating income
-४७.९१ लाख
-४४.७१ लाख
-५३.५४ लाख
-४६.८१ लाख
Other non operating income
-
-
-
-
EBT including unusual items
-४७.३५ लाख
-४४.६७ लाख
-५४.२६ लाख
-४५.७२ लाख
EBT excluding unusual items
-४७.३५ लाख
-४४.६७ लाख
-५४.२६ लाख
-४५.७२ लाख
Income tax expense
५.४९ लाख
७०.१२ हजार
१.८३ लाख
१.०४ लाख
Effective tax rate
-११.६०%
-१.५७%
-३.३७%
-२.२८%
Other operating expenses
-
-
-
-
Net income
-५२.८४ लाख
-४५.३८ लाख
-५६.०९ लाख
-४६.७६ लाख
Net profit margin
-
-
-
-
Earnings per share
-०.१५
-०.११
-०.१३
-०.११
Interest and investment income
८३.३० हजार
८८.५८ हजार
९३.३४ हजार
६०.७३ हजार
Interest expense
-
-
-
-
Net interest expenses
८३.३० हजार
८८.५८ हजार
९३.३४ हजार
६०.७३ हजार
Depreciation and amortization charges
-
-
-
-
EBITDA
-४७.८० लाख
-४४.५६ लाख
-५३.४५ लाख
-४६.६७ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू